Schizophrenia Disorders
39
23
26
5
Key Insights
Highlights
Success Rate
71% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
5.1%
2 terminated out of 39 trials
71.4%
-15.1% vs benchmark
3%
1 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (39)
Transition Care for FEP
Medical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients
The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia.
SEEG-Guided DBS for Schizophrenia
Non-Coding RNAs Gene Expression in Psychiatric Disorders
Recovery in Telling Life Stories
Cognitive Remediation Method Using Rhythmic, Vocal and Corporal Musical Learning for Schizophrenia
Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy
The Key to Integrated Trauma Treatment in Psychosis Trial
Arts-based Social Prescribing for Mental Health
Brain Stimulation to the Hippocampus in Schizophrenia
White Matter Plasticity in Schizophrenia
Investigating the Effect of Diroximel Fumarate on Glutathione in Schizophrenia
Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder
Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy
Visual Perception in Schizophrenia
Creating a Global Research Database That Connects Genetic Information and Long-term Health Data to Improve Personalized Treatment for People With Serious Mental Illness
Activities to Change Your Mood: A Test of the Acceptability and Initial Efficacy in Clinical Samples and Healthy Controls
Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for Psychosis
Occurrence and Influencing Factors of Cognitive Impairment in Elderly Patients With Schizophrenia and